The Contribution of Melanocyte-like Cells to Atrial Function and Development
黑素细胞样细胞对心房功能和发育的贡献
基本信息
- 批准号:8848105
- 负责人:
- 金额:$ 44.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAdrenergic ReceptorAffectAnatomyAnimal ModelArrhythmiaAtrial FibrillationAtrial FunctionBiologicalBiologyCalciumCarbacholCardiacCell LineageCellsCharacteristicsClinicalCouplingDataDermalDevelopmentDiseaseDopachrome isomeraseElderlyElectrophysiology (science)EngineeringEnzymesExhibitsGap JunctionsGated Ion ChannelGene Expression ProfileGenerationsGenesGeneticGenetic TranscriptionGenetically Engineered MouseGoalsHeartHeart AtriumHeterozygoteHumanIn VitroInvestigationIonsKnockout MiceKnowledgeLaboratoriesLeadManganese Superoxide DismutaseMapsModelingMonophenol MonooxygenaseMusMuscarinic Acetylcholine ReceptorMuscarinic AgonistsMuscle CellsMutant Strains MiceMyocardiumOpticsOxidantsPatch-Clamp TechniquesPathogenesisPathologicPatternPhysiologicalPhysiologyPlayPopulationPredispositionPropertyProto-Oncogene Protein c-kitPublishingPulmonary veinsReactive Oxygen SpeciesResearch PersonnelRoleSeriesSiteSodium-Calcium ExchangerStagingStimulusStressTechniquesTestingWild Type MouseWorkbasedesignheart rhythmimprovedin vivoinsightmelanocytemouse modelnoveloxidative damagereceptorresearch studyresponsevoltage
项目摘要
DESCRIPTION (provided by applicant): We recently described a novel population of melanocyte-like cells in the pulmonary veins and atria of humans and mice. In the developing and mature heart, melanocyte-like cells are found in a pattern unlike that of any currently known cell lineage and are found in anatomic regions that often give rise to clinical atrial arrhythmia triggers. These cells express a unique transcription signature that is distinct from that of atrial myocytes or dermal melanocytes. Interestingly, isolated murine melanocyte-like cells are electrically excitable and generate atrial myocyte-like action potentials. We have found that genetic deletion of the enzyme dopachrome tautomerase (Dct), which is expressed by both human and murine cardiac melanocytes, unmasks a pathological state with action potential prolongation and afterdepolarizations in these cells. Furthermore, mature Dct knockout mice retain melanocyte-like cells and have structurally normal hearts, yet display increased susceptibility to atrial arrhythmias. While wild-type mice with melanocyte-like cells in their hearts do not have increased atrial arrhythmias at baseline, they do have more atrial arrhythmias when challenged with the muscarinic agonist carbachol compared to c-kit mutant mice that lack melanocyte-like cells in their hearts. In addition, Dct knockout mice have fewer atrial arrhythmias when treated with reactive oxygen species scavengers. Hence, melanocyte-like cells may contribute to atrial arrhythmias in response to increased stresses (i.e. autonomic stimulation or reactive oxygen species) that commonly induce clinical atrial arrhythmias. Despite our initial characterization, the function of melanocyte-like cells during normal physiologic and pathophysiologic states remains obscure. Furthermore, while we have some evidence melanocyte-like cells are excitable and may influence arrhythmogenesis; the underlying electrophysiologic characteristics of these cells require further investigation to understand their potential contribution to arrhythmias. Therefore, we are proposing a series of in vitro and in vivo experiments using genetically engineered mouse models to characterize the cellular electrophysiology of these cells and determine their contribution to atrial arrhythmias. The specific aims proposed include: 1) elucidating the voltage-dependent currents underlying the electrical excitability of isolated murine melanocyte-like cells and the direct contribution of melanocyte-like to atrial arrhythmia triggers, 2) determining the effects of autonomic stimulation upon Dct-positive melanocyte-like cellular excitability and their contribution atrial arrhythmias, 3) assessing the effects of reactive oxygen species upon the excitability of Dct-positive melanocyte-like cells and their influence upon atrial arrhythmias, and 4) investigating the role of melanocyte-like cells in the normal heart. The knowledge we will gain about the basic biology of melanocyte-like cells is likely to open new avenues in our understanding of atrial electrophysiology, with the potential for paradigm shifting insights into the pathogenesis of atrial arrhythmias.
描述(由申请人提供):我们最近描述了人类和小鼠肺静脉和心房中的一种新的黑素细胞样细胞群。在发育和成熟的心脏中,发现黑素细胞样细胞的模式与任何目前已知的细胞谱系不同,并且发现于经常引起临床房性心律失常触发的解剖区域。这些细胞表达一种独特的转录特征,与心房肌细胞或真皮黑素细胞的转录特征不同。有趣的是,分离的鼠黑素细胞样细胞是电兴奋的,并产生心房肌细胞样动作电位。我们已经发现,基因缺失的酶多巴色素互变异构酶(Dct),这是由人类和小鼠的心脏黑素细胞表达,揭示了这些细胞中的动作电位延长和后去极化的病理状态。此外,成熟的Dct敲除小鼠保留黑素细胞样细胞,心脏结构正常,但对房性心律失常的易感性增加。虽然心脏中有黑素细胞样细胞的野生型小鼠在基线时没有增加房性心律失常,但与心脏中缺乏黑素细胞样细胞的c-kit突变小鼠相比,当用毒蕈碱激动剂卡巴胆碱激发时,它们确实有更多的房性心律失常。此外,Dct敲除小鼠在用活性氧清除剂治疗时具有较少的房性心律失常。因此,黑素细胞样细胞可能有助于房性心律失常,以响应增加的应激(即自主神经刺激或活性氧),通常诱导临床房性心律失常。尽管我们最初的特征,黑素细胞样细胞在正常的生理和病理生理状态的功能仍然不清楚。此外,虽然我们有一些证据表明黑素细胞样细胞是可兴奋的,可能会影响心律失常,这些细胞的潜在电生理特征需要进一步研究,以了解其对心律失常的潜在贡献。因此,我们提出了一系列的体外和体内实验,使用基因工程小鼠模型来表征这些细胞的细胞电生理学,并确定其对房性心律失常的贡献。拟议的具体目标包括:1)阐明分离的鼠黑素细胞样细胞的电兴奋性的电压依赖性电流和黑素细胞样对房性心律失常触发的直接贡献,2)确定自主刺激对Dct阳性黑素细胞样细胞兴奋性的影响和它们对房性心律失常的贡献,3)评估活性氧对Dct阳性黑素细胞样细胞的兴奋性的影响以及它们对房性心律失常的影响,以及4)研究黑素细胞样细胞在正常心脏中的作用。我们将获得有关黑素细胞样细胞的基础生物学知识,这可能为我们理解心房电生理学开辟新的途径,并有可能改变对房性心律失常发病机制的认识。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Local innervation and atrial fibrillation.
- DOI:10.1161/circulationaha.113.001596
- 发表时间:2013-10-01
- 期刊:
- 影响因子:37.8
- 作者:Wickramasinghe SR;Patel VV
- 通讯作者:Patel VV
GATA-Binding Factor 6 Contributes to Atrioventricular Node Development and Function.
- DOI:10.1161/circgenetics.113.000587
- 发表时间:2015-04
- 期刊:
- 影响因子:0
- 作者:Liu F;Lu MM;Patel NN;Schillinger KJ;Wang T;Patel VV
- 通讯作者:Patel VV
Inappropriate ICD shocks caused by T-wave oversensing due to acute alcohol intoxication.
急性酒精中毒导致 T 波过度敏感而导致 ICD 电击不当。
- DOI:10.1111/j.1540-8159.2012.03348.x
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Rasania,SurajP;Mountantonakis,Stavros;Patel,VickasV
- 通讯作者:Patel,VickasV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiongwen Chen其他文献
Xiongwen Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiongwen Chen', 18)}}的其他基金
Compartmental PKA and Pathological Cardiac Hypertrophy
室室 PKA 和病理性心脏肥大
- 批准号:
9595818 - 财政年份:2018
- 资助金额:
$ 44.77万 - 项目类别:
Ca2+-Influx Regulated Cardiac Hypertrophy, Arrhythmia and Myocyte Apoptosis
Ca2 流入调节心脏肥大、心律失常和心肌细胞凋亡
- 批准号:
7837531 - 财政年份:2009
- 资助金额:
$ 44.77万 - 项目类别:
Ca2+-Influx Regulated Cardiac Hypertrophy, Arrhythmia and Myocyte Apoptosis
Ca2 流入调节心脏肥大、心律失常和心肌细胞凋亡
- 批准号:
7459040 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Ca2+-Influx Regulated Cardiac Hypertrophy, Arrhythmia and Myocyte Apoptosis
Ca2 流入调节心脏肥大、心律失常和心肌细胞凋亡
- 批准号:
7245545 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Ca2+-Influx Regulated Cardiac Hypertrophy, Arrhythmia and Myocyte Apoptosis
Ca2 流入调节心脏肥大、心律失常和心肌细胞凋亡
- 批准号:
7807164 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Protein Kinase A Inhibitor Peptide (PKI) and Cardiac Protection in Heart Failure
蛋白激酶 A 抑制肽 (PKI) 与心力衰竭的心脏保护
- 批准号:
8704986 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Ca2+-Influx Regulated Cardiac Hypertrophy, Arrhythmia and Myocyte Apoptosis
Ca2 流入调节心脏肥大、心律失常和心肌细胞凋亡
- 批准号:
7617211 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Protein Kinase A Inhibitor Peptide (PKI) and Cardiac Protection in Heart Failure
蛋白激酶 A 抑制肽 (PKI) 与心力衰竭的心脏保护
- 批准号:
9283610 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Protein Kinase A Inhibitor Peptide (PKI) and Cardiac Protection in Heart Failure
蛋白激酶 A 抑制肽 (PKI) 与心力衰竭的心脏保护
- 批准号:
8860229 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
Protein Kinase A Inhibitor Peptide (PKI) and Cardiac Protection in Heart Failure
蛋白激酶 A 抑制肽 (PKI) 与心力衰竭的心脏保护
- 批准号:
8580498 - 财政年份:2007
- 资助金额:
$ 44.77万 - 项目类别:
相似海外基金
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 44.77万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
- 批准号:
RGPIN-2019-04706 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
- 批准号:
22K07118 - 财政年份:2022
- 资助金额:
$ 44.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




